ROMIDEPSIN

ROMIDEPSIN was reported 1689 times

ROMIDEPSIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 T-CELL LYMPHOMA UNCLASSIFIABLE 1 0.5000
1 MYCOSIS FUNGOIDES REFRACTORY 2 0.3333
2 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY 3 0.2308
3 CD34 CELL COUNT DECREASED 2 0.2000
4 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 118 0.1993
5 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 40 0.1274
6 MYCOSIS FUNGOIDES RECURRENT 3 0.1034
7 MYCOSIS FUNGOIDES STAGE IV 2 0.0690
8 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV 3 0.0667
9 CUTANEOUS T-CELL LYMPHOMA STAGE II 1 0.0455
10 DIPHTHERIA 2 0.0426
11 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT 1 0.0385
12 ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES RECURRENT 1 0.0357
13 ANAPLASTIC LARGE-CELL LYMPHOMA 8 0.0339
14 MUCOSAL PIGMENTATION 1 0.0333
15 ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA 2 0.0328
16 T-CELL LYMPHOMA RECURRENT 2 0.0328
17 HTLV-1 TEST POSITIVE 1 0.0303
18 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT 2 0.0299
19 INFECTIOUS DISEASE CARRIER 1 0.0213
20 T-CELL LYMPHOMA 22 0.0192
21 INJECTION SITE VASCULITIS 1 0.0175
22 HYPOZINCAEMIA 1 0.0169
23 LICHEN MYXOEDEMATOSUS 1 0.0169
24 INFECTIVE AORTITIS 1 0.0167
25 CUTANEOUS T-CELL LYMPHOMA RECURRENT 1 0.0159
26 GASTRIC PNEUMATOSIS 1 0.0141
27 MYCOSIS FUNGOIDES 11 0.0134
28 MALIGNANT MESENTERIC NEOPLASM 1 0.0132
29 SINUSITIS ASPERGILLUS 2 0.0127
30 MEIBOMIANITIS 1 0.0111
31 NON-HODGKIN'S LYMPHOMA RECURRENT 1 0.0109
32 INFUSION SITE ULCER 1 0.0109
33 T-CELL PROLYMPHOCYTIC LEUKAEMIA 1 0.0108
34 HEMICEPHALALGIA 1 0.0101
35 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 1 0.0098
36 CUTANEOUS T-CELL LYMPHOMA 12 0.0095
37 ANAL EROSION 1 0.0091
38 CLOSTRIDIUM DIFFICILE SEPSIS 1 0.0089
39 SCLERAL HAEMORRHAGE 2 0.0087
40 NECROTIC LYMPHADENOPATHY 1 0.0083
41 CANCER IN REMISSION 2 0.0083
42 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 9 0.0068
43 ABDOMINAL WALL WOUND 1 0.0065
44 IMMUNOLOGY TEST ABNORMAL 1 0.0064
45 MEDIASTINUM NEOPLASM 1 0.0060
46 INTERLEUKIN-2 RECEPTOR INCREASED 1 0.0058
47 PLASMABLASTIC LYMPHOMA 2 0.0056
48 METASTASES TO NERVOUS SYSTEM 1 0.0054
49 HEPATOSPLENIC T-CELL LYMPHOMA 2 0.0054
50 NEUTROPHILIC DERMATOSIS 2 0.0051
51 LYMPHOCYTIC LEUKAEMIA 2 0.0049
52 CUTANEOUS LYMPHOMA 1 0.0049
53 TUMOUR ASSOCIATED FEVER 2 0.0049
54 ORAL DYSAESTHESIA 1 0.0049
55 GLOMERULONEPHRITIS ACUTE 1 0.0049
56 REFRACTORY CANCER 1 0.0047
57 DISSEMINATED CYTOMEGALOVIRAL INFECTION 1 0.0046
58 LYMPH GLAND INFECTION 2 0.0044
59 PELVI-URETERIC OBSTRUCTION 1 0.0043
60 PLEURAL INFECTION 1 0.0043
61 MUCOSAL INFECTION 1 0.0043
62 VIRAL HAEMORRHAGIC CYSTITIS 3 0.0042
63 BIOPSY SKIN ABNORMAL 1 0.0041
64 CLOSTRIDIAL SEPSIS 1 0.0041
65 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 2 0.0041
66 INFESTATION 1 0.0039
67 HERPES ZOSTER REACTIVATION 1 0.0038
68 BLOOD MAGNESIUM ABNORMAL 2 0.0036
69 OESOPHAGITIS HAEMORRHAGIC 1 0.0036
70 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 2 0.0034
71 TUMOUR LYSIS SYNDROME 29 0.0033
72 DEVICE RELATED BACTERAEMIA 1 0.0032
73 PRODUCT STORAGE ISSUE 12 0.0032
74 VOCAL CORD THICKENING 1 0.0031
75 HAEMATOLOGY TEST ABNORMAL 1 0.0031
76 CELLULITE 1 0.0031
77 TROPONIN I INCREASED 5 0.0030
78 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 1 0.0029
79 TUMOUR FLARE 2 0.0029
80 LARGE INTESTINAL ULCER HAEMORRHAGE 1 0.0029
81 GLOMERULONEPHRITIS PROLIFERATIVE 1 0.0028
82 RESPIRATORY TRACT OEDEMA 2 0.0027
83 MEDIASTINAL MASS 1 0.0026
84 CYTOMEGALOVIRUS CHORIORETINITIS 5 0.0026
85 PULMONARY NOCARDIOSIS 2 0.0024
86 PLEUROPERICARDITIS 1 0.0024
87 CAMPYLOBACTER INFECTION 2 0.0024
88 TRANSPLANTATION COMPLICATION 1 0.0024
89 DIABETIC HYPEROSMOLAR COMA 1 0.0023
90 HYPERFERRITINAEMIA 1 0.0023
91 MENINGOENCEPHALITIS HERPETIC 1 0.0022
92 OROPHARYNGEAL CANDIDIASIS 2 0.0022
93 CEREBRAL MICROHAEMORRHAGE 1 0.0022
94 PULMONARY EOSINOPHILIA 1 0.0022
95 BODY MASS INDEX DECREASED 1 0.0022
96 WOLFF-PARKINSON-WHITE SYNDROME 1 0.0021
97 KLEBSIELLA BACTERAEMIA 2 0.0021
98 VITREOUS DISORDER 1 0.0021
99 TUMOUR INVASION 1 0.0021
100 MESENTERIC VEIN THROMBOSIS 2 0.0020
101 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1 0.0020
102 ELECTROCARDIOGRAM QT PROLONGED 71 0.0020
103 CYTOPENIA 24 0.0020
104 INFUSION SITE VESICLES 1 0.0019
105 INFUSION SITE CELLULITIS 1 0.0019
106 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 4 0.0019
107 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 14 0.0019
108 HYPEREOSINOPHILIC SYNDROME 1 0.0018
109 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
110 BLOOD PH INCREASED 1 0.0018
111 MALIGNANT PLEURAL EFFUSION 3 0.0018
112 INTRACRANIAL HAEMATOMA 1 0.0018
113 RADIATION NECROSIS 1 0.0017
114 THERAPY PARTIAL RESPONDER 26 0.0017
115 URINARY TRACT INFECTION PSEUDOMONAL 1 0.0017
116 SOFT TISSUE INFECTION 3 0.0016
117 PNEUMONIA KLEBSIELLA 3 0.0016
118 HEPATOBILIARY DISEASE 1 0.0016
119 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
120 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
121 CYTOMEGALOVIRUS INFECTION REACTIVATION 7 0.0016
122 HAEMATOTOXICITY 15 0.0016
123 CYTOMEGALOVIRUS VIRAEMIA 7 0.0016
124 CHALAZION 1 0.0016
125 PAROTID GLAND ENLARGEMENT 1 0.0015
126 HYPERMAGNESAEMIA 1 0.0015
127 TUMOUR PAIN 2 0.0015
128 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
129 CYTOKINE STORM 1 0.0015
130 EXTRAVASATION 6 0.0015
131 EPSTEIN-BARR VIRUS INFECTION 9 0.0014
132 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
133 DIFFUSE LARGE B-CELL LYMPHOMA 11 0.0014
134 ACUTE PULMONARY OEDEMA 8 0.0014
135 PREGNANCY OF PARTNER 1 0.0014
136 FEBRILE BONE MARROW APLASIA 6 0.0014
137 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
138 VASOGENIC CEREBRAL OEDEMA 1 0.0014
139 PYODERMA GANGRENOSUM 5 0.0014
140 HODGKIN'S DISEASE 1 0.0014
141 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
142 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 3 0.0014
143 OTITIS MEDIA ACUTE 1 0.0014
144 METAPNEUMOVIRUS INFECTION 1 0.0013
145 BRONCHIAL CARCINOMA 1 0.0013
146 ENDOCARDITIS BACTERIAL 1 0.0013
147 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 1 0.0013
148 AORTIC DISORDER 1 0.0013
149 GRAFT VERSUS HOST DISEASE 9 0.0013
150 SINUSITIS FUNGAL 1 0.0012
151 BRADYARRHYTHMIA 2 0.0012
152 HYPOPYON 1 0.0012
153 INFUSION SITE OEDEMA 1 0.0012
154 PERITONSILLAR ABSCESS 1 0.0012
155 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 6 0.0012
156 PSEUDOMONAL BACTERAEMIA 1 0.0012
157 SERUM FERRITIN DECREASED 2 0.0012
158 RETINITIS 2 0.0012
159 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
160 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
161 SPLENIC INFARCTION 2 0.0011
162 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
163 LYMPHOPENIA 16 0.0011
164 INFUSION SITE EXTRAVASATION 7 0.0011
165 HUMAN CHORIONIC GONADOTROPIN INCREASED 1 0.0011
166 INVASIVE DUCTAL BREAST CARCINOMA 3 0.0011
167 PREMATURE MENOPAUSE 1 0.0011
168 THROMBOCYTOPENIA 120 0.0011
169 ELECTROCARDIOGRAM CHANGE 1 0.0011
170 CARDIAC TAMPONADE 5 0.0011
171 NEUTROPENIC INFECTION 1 0.0010
172 HEPATIC MASS 2 0.0010
173 TELANGIECTASIA 1 0.0010
174 ESCHERICHIA SEPSIS 3 0.0010
175 HYPOALBUMINAEMIA 8 0.0010
176 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
177 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
178 IDIOSYNCRATIC DRUG REACTION 1 0.0010
179 RECTAL POLYP 1 0.0010
180 STAPHYLOCOCCAL SEPSIS 5 0.0010
181 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
182 CELL DEATH 2 0.0010
183 CYSTITIS HAEMORRHAGIC 4 0.0010
184 AUTONOMIC NEUROPATHY 1 0.0010
185 ENTEROCOCCAL BACTERAEMIA 1 0.0009
186 RADIATION INJURY 1 0.0009
187 TRAUMATIC HAEMATOMA 1 0.0009
188 LYMPHOCYTOSIS 2 0.0009
189 STREPTOCOCCAL BACTERAEMIA 1 0.0009
190 KIDNEY ENLARGEMENT 1 0.0009
191 PRODUCT NAME CONFUSION 1 0.0009
192 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
193 TINEA INFECTION 1 0.0009
194 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
195 EPSTEIN-BARR VIRAEMIA 1 0.0009
196 CARDIOTOXICITY 8 0.0009
197 KLEBSIELLA SEPSIS 1 0.0009
198 PUPILS UNEQUAL 1 0.0009
199 ACUTE GRAFT VERSUS HOST DISEASE 4 0.0009
200 AORTIC THROMBOSIS 1 0.0009
201 LOCALISED OEDEMA 4 0.0009
202 MUCOSAL HAEMORRHAGE 1 0.0009
203 RADIATION SKIN INJURY 1 0.0009
204 PAROTITIS 1 0.0009
205 FEBRILE INFECTION 1 0.0008
206 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
207 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
208 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
209 CARDIAC DEATH 1 0.0008
210 PANNICULITIS 2 0.0008
211 CLOSTRIDIUM COLITIS 1 0.0008
212 OTITIS EXTERNA 1 0.0008
213 INFUSION SITE WARMTH 1 0.0008
214 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
215 LARGE INTESTINE INFECTION 1 0.0008
216 CARDIAC DYSFUNCTION 3 0.0008
217 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
218 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
219 LUNG INFILTRATION 7 0.0008
220 LYMPHOCYTE COUNT DECREASED 14 0.0008
221 DERMATOMYOSITIS 2 0.0008
222 MALLORY-WEISS SYNDROME 1 0.0008
223 LYMPHOMA 12 0.0008
224 ACUTE MYELOID LEUKAEMIA 12 0.0008
225 CARDIOPULMONARY FAILURE 3 0.0008
226 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
227 ENCEPHALITIS AUTOIMMUNE 1 0.0008
228 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
229 URETERIC OBSTRUCTION 1 0.0007
230 PRODUCT STORAGE ERROR 64 0.0007
231 HYPERURICAEMIA 3 0.0007
232 MENINGITIS VIRAL 1 0.0007
233 FEBRILE NEUTROPENIA 48 0.0007
234 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
235 VIRAEMIA 1 0.0007
236 CYTOMEGALOVIRUS INFECTION 12 0.0007
237 H1N1 INFLUENZA 1 0.0007
238 NEUTROPHIL COUNT ABNORMAL 2 0.0007
239 BUNDLE BRANCH BLOCK LEFT 3 0.0007
240 PLATELET COUNT DECREASED 74 0.0007
241 PULMONARY SEPSIS 1 0.0007
242 NEUTROPHIL COUNT DECREASED 28 0.0007
243 PNEUMONIA PNEUMOCOCCAL 1 0.0007
244 IMPETIGO 1 0.0007
245 MOUTH ULCERATION 14 0.0007
246 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
247 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
248 PNEUMONIA PSEUDOMONAL 1 0.0007
249 UROSEPSIS 6 0.0006
250 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
251 SINUS ARREST 1 0.0006
252 FUNGAEMIA 1 0.0006
253 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
254 ATRIAL FIBRILLATION 61 0.0006
255 GASTROINTESTINAL TOXICITY 3 0.0006
256 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
257 QUADRIPARESIS 1 0.0006
258 CARDIAC FAILURE ACUTE 4 0.0006
259 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
260 BACTERAEMIA 7 0.0006
261 BLOOD AMYLASE INCREASED 1 0.0006
262 PSEUDOMONAL SEPSIS 1 0.0006
263 BURNS SECOND DEGREE 1 0.0006
264 DISSEMINATED INTRAVASCULAR COAGULATION 8 0.0006
265 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
266 SINUS TACHYCARDIA 8 0.0006
267 JUGULAR VEIN THROMBOSIS 1 0.0006
268 DISEASE PROGRESSION 66 0.0006
269 MONOPARESIS 1 0.0006
270 WOUND INFECTION 6 0.0005
271 BONE MARROW FAILURE 11 0.0005
272 HYPOPHOSPHATAEMIA 4 0.0005
273 VITRITIS 1 0.0005
274 GRANULOCYTE COUNT DECREASED 1 0.0005
275 INTERVERTEBRAL DISCITIS 1 0.0005
276 INFECTED SKIN ULCER 1 0.0005
277 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
278 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
279 ELECTROLYTE IMBALANCE 6 0.0005
280 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
281 AMENORRHOEA 9 0.0005
282 HYPOGEUSIA 1 0.0005
283 MALIGNANT NEOPLASM PROGRESSION 52 0.0005
284 PNEUMONIA FUNGAL 2 0.0005
285 ATRIAL FLUTTER 4 0.0005
286 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
287 HEPATITIS B 3 0.0005
288 PLATELET COUNT ABNORMAL 3 0.0005
289 EAR HAEMORRHAGE 1 0.0005
290 TASTE DISORDER 10 0.0005
291 HYPERCALCAEMIA 6 0.0005
292 ACUTE CORONARY SYNDROME 4 0.0005
293 VARICELLA ZOSTER VIRUS INFECTION 1 0.0005
294 SUBILEUS 1 0.0005
295 CONGESTIVE CARDIOMYOPATHY 2 0.0005
296 LUNG ABSCESS 1 0.0005
297 ANAEMIA MACROCYTIC 1 0.0005
298 HAEMOGLOBIN ABNORMAL 3 0.0005
299 NEUTROPENIA 63 0.0005
300 PANCYTOPENIA 25 0.0004
301 HAEMOLYTIC ANAEMIA 4 0.0004
302 GASTRIC POLYPS 1 0.0004
303 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
304 PERIARTHRITIS 1 0.0004
305 LICHENOID KERATOSIS 1 0.0004
306 HAEMANGIOMA 1 0.0004
307 HYPOMAGNESAEMIA 6 0.0004
308 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
309 MULTIPLE MYELOMA 2 0.0004
310 ESCHERICHIA BACTERAEMIA 1 0.0004
311 VENTRICULAR TACHYCARDIA 7 0.0004
312 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
313 ANAEMIA 80 0.0004
314 NON-SMALL CELL LUNG CANCER 2 0.0004
315 SUBCUTANEOUS ABSCESS 2 0.0004
316 LONG QT SYNDROME 1 0.0004
317 LYMPHADENITIS 1 0.0004
318 MOUTH HAEMORRHAGE 3 0.0004
319 TRANSPLANT FAILURE 1 0.0004
320 ORGANISING PNEUMONIA 2 0.0004
321 DERMATITIS EXFOLIATIVE 2 0.0004
322 SYSTEMIC CANDIDA 1 0.0004
323 PAROSMIA 3 0.0004
324 PLATELET DISORDER 1 0.0004
325 KLEBSIELLA INFECTION 2 0.0004
326 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
327 ABDOMINAL INFECTION 1 0.0004
328 ENDOCARDITIS 2 0.0004
329 HEPATOSPLENOMEGALY 1 0.0004
330 LEUKOCYTOSIS 7 0.0004
331 PERIORBITAL OEDEMA 2 0.0004
332 FAILURE TO THRIVE 2 0.0004
333 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
334 FOLLICULITIS 4 0.0004
335 ORAL CANDIDIASIS 5 0.0004
336 SERUM FERRITIN INCREASED 2 0.0004
337 BACTERIAL INFECTION 7 0.0004
338 ABDOMINAL MASS 1 0.0004
339 BLOOD SODIUM INCREASED 1 0.0004
340 HYPOCALCAEMIA 7 0.0004
341 HEPATIC FAILURE 11 0.0004
342 PLEURITIC PAIN 1 0.0004
343 EMBOLISM 3 0.0004
344 RASH MORBILLIFORM 1 0.0004
345 CYTOKINE RELEASE SYNDROME 7 0.0003
346 BLOOD MAGNESIUM DECREASED 3 0.0003
347 HERPES VIRUS INFECTION 2 0.0003
348 MULTI-ORGAN FAILURE 6 0.0003
349 BLOOD URIC ACID INCREASED 2 0.0003
350 MYELODYSPLASTIC SYNDROME 5 0.0003
351 MUCOSAL INFLAMMATION 9 0.0003
352 PRODUCT LABEL CONFUSION 2 0.0003
353 HYPERTRIGLYCERIDAEMIA 2 0.0003
354 SPLENOMEGALY 4 0.0003
355 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
356 SINUS HEADACHE 2 0.0003
357 LUNG ADENOCARCINOMA 1 0.0003
358 SEPSIS 37 0.0003
359 RETINAL DETACHMENT 3 0.0003
360 INTRACARDIAC THROMBUS 1 0.0003
361 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
362 DEVICE RELATED INFECTION 5 0.0003
363 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
364 INJECTION SITE EXTRAVASATION 4 0.0003
365 MENTAL STATUS CHANGES 9 0.0003
366 LUNG INFECTION 5 0.0003
367 HEPATIC FUNCTION ABNORMAL 12 0.0003
368 INJECTION SITE HYPERSENSITIVITY 1 0.0003
369 BLOOD CREATININE DECREASED 1 0.0003
370 LEUKAEMIA 3 0.0003
371 INFUSION SITE PRURITUS 1 0.0003
372 NON-CARDIAC CHEST PAIN 1 0.0003
373 LIVER DISORDER 14 0.0003
374 ORTHOPNOEA 1 0.0003
375 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
376 ACUTE RESPIRATORY FAILURE 6 0.0003
377 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
378 PORTAL VEIN THROMBOSIS 1 0.0003
379 INCORRECT DISPOSAL OF PRODUCT 1 0.0003
380 BACTERIAL SEPSIS 1 0.0003
381 LYMPHOCYTE COUNT INCREASED 1 0.0003
382 MYELOSUPPRESSION 11 0.0003
383 PRODUCT PREPARATION ISSUE 2 0.0003
384 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
385 DEAFNESS NEUROSENSORY 1 0.0003
386 PYREXIA 105 0.0003
387 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
388 BK VIRUS INFECTION 1 0.0003
389 BLOOD BILIRUBIN INCREASED 8 0.0003
390 B-CELL LYMPHOMA 1 0.0003
391 BRONCHOPNEUMONIA 1 0.0003
392 WOUND COMPLICATION 1 0.0003
393 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
394 ORTHOSTATIC HYPOTENSION 5 0.0003
395 THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.0003
396 SUDDEN DEATH 3 0.0003
397 HEPATOCELLULAR INJURY 4 0.0003
398 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
399 FIBRIN D DIMER INCREASED 1 0.0003
400 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
401 NEUTROPENIC SEPSIS 2 0.0003
402 PLEURAL EFFUSION 17 0.0003
403 SEPTIC SHOCK 12 0.0003
404 OESOPHAGITIS 3 0.0003
405 VENTRICULAR ARRHYTHMIA 1 0.0003
406 AMYLASE INCREASED 1 0.0003
407 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
408 CARDIOMYOPATHY 4 0.0003
409 HAEMORRHAGE INTRACRANIAL 4 0.0003
410 PROTEIN TOTAL DECREASED 1 0.0003
411 MITRAL VALVE INCOMPETENCE 3 0.0003
412 CHEMOTHERAPY 1 0.0003
413 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
414 TROPONIN INCREASED 2 0.0003
415 TONGUE OEDEMA 1 0.0003
416 LIPASE INCREASED 2 0.0003
417 HYPOKALAEMIA 12 0.0003
418 LEUKOPENIA 13 0.0003
419 ATRIOVENTRICULAR BLOCK 2 0.0003
420 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
421 DECREASED APPETITE 60 0.0003
422 VIRAL LOAD INCREASED 1 0.0003
423 DYSGEUSIA 19 0.0003
424 ULCER 4 0.0003
425 OESOPHAGEAL CANDIDIASIS 1 0.0003
426 MUSCLE HAEMORRHAGE 1 0.0002
427 HYPONATRAEMIA 14 0.0002
428 FULL BLOOD COUNT DECREASED 5 0.0002
429 APPLICATION SITE DISCOLOURATION 1 0.0002
430 SMALL INTESTINAL OBSTRUCTION 3 0.0002
431 HICCUPS 2 0.0002
432 ANAPHYLACTOID REACTION 1 0.0002
433 PHARYNGITIS 3 0.0002
434 SECOND PRIMARY MALIGNANCY 2 0.0002
435 FACE OEDEMA 4 0.0002
436 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
437 CARDIAC FAILURE CHRONIC 1 0.0002
438 ABSCESS LIMB 1 0.0002
439 FACIAL PARALYSIS 2 0.0002
440 RESPIRATORY FAILURE 17 0.0002
441 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
442 MONOPLEGIA 1 0.0002
443 URINE OUTPUT DECREASED 2 0.0002
444 MELAENA 5 0.0002
445 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
446 LYMPHADENOPATHY 8 0.0002
447 RHINITIS ALLERGIC 1 0.0002
448 SUSPECTED OFF LABEL USE 1 0.0002
449 VASCULAR DEVICE INFECTION 1 0.0002
450 C-REACTIVE PROTEIN INCREASED 8 0.0002
451 HYPERGLYCAEMIA 8 0.0002
452 SKIN LESION 6 0.0002
453 IMMUNE THROMBOCYTOPENIA 1 0.0002
454 GASTRITIS EROSIVE 1 0.0002
455 FEELING OF DESPAIR 1 0.0002
456 PERFORMANCE STATUS DECREASED 1 0.0002
457 APPENDICITIS 2 0.0002
458 SQUAMOUS CELL CARCINOMA 2 0.0002
459 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
460 FRACTURE 4 0.0002
461 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
462 ATELECTASIS 2 0.0002
463 ENTEROCOCCAL INFECTION 1 0.0002
464 SINUS BRADYCARDIA 2 0.0002
465 THROMBOTIC MICROANGIOPATHY 2 0.0002
466 PLASMA CELL MYELOMA 8 0.0002
467 RENAL TUBULAR NECROSIS 2 0.0002
468 ENCEPHALOPATHY 5 0.0002
469 BODY TEMPERATURE DECREASED 2 0.0002
470 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
471 HYPERVOLAEMIA 1 0.0002
472 NEOPLASM PROGRESSION 7 0.0002
473 HYPERNATRAEMIA 1 0.0002
474 SALIVARY HYPERSECRETION 2 0.0002
475 CARDIAC FAILURE 16 0.0002
476 CORONARY ARTERY STENOSIS 1 0.0002
477 CELLULITIS 10 0.0002
478 STOMATITIS 12 0.0002
479 TOXIC ENCEPHALOPATHY 1 0.0002
480 PATHOLOGICAL FRACTURE 1 0.0002
481 EJECTION FRACTION DECREASED 3 0.0002
482 PETECHIAE 2 0.0002
483 TONSILLITIS 1 0.0002
484 DEAFNESS 5 0.0002
485 ARRHYTHMIA 9 0.0002
486 BLOOD LACTIC ACID INCREASED 1 0.0002
487 POLYARTHRITIS 1 0.0002
488 CHILLS 22 0.0002
489 CHEILITIS 1 0.0002
490 FAECALOMA 1 0.0002
491 NONSPECIFIC REACTION 1 0.0002
492 PHOTOSENSITIVITY REACTION 3 0.0002
493 INTESTINAL ISCHAEMIA 1 0.0002
494 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
495 TRANSAMINASES INCREASED 4 0.0002
496 INFECTION 26 0.0002
497 BLOOD UREA INCREASED 3 0.0002
498 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
499 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
500 SKIN TOXICITY 1 0.0002
501 CHOLECYSTITIS ACUTE 1 0.0002
502 GRANULOCYTOPENIA 1 0.0002
503 MYOCARDITIS 2 0.0002
504 EPISTAXIS 13 0.0002
505 ENTEROCOLITIS 1 0.0002
506 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
507 HYPOVOLAEMIA 1 0.0002
508 URINE ODOUR ABNORMAL 1 0.0002
509 ACUTE MYOCARDIAL INFARCTION 5 0.0002
510 CHOLECYSTITIS 2 0.0002
511 PROTHROMBIN TIME PROLONGED 1 0.0002
512 VOMITING 78 0.0002
513 DERMATITIS ACNEIFORM 1 0.0002
514 NO THERAPEUTIC RESPONSE 2 0.0002
515 CONJUNCTIVITIS 3 0.0002
516 GENERALISED OEDEMA 2 0.0002
517 AGEUSIA 4 0.0002
518 PNEUMONIA ASPIRATION 4 0.0002
519 BLOOD URINE PRESENT 3 0.0002
520 NAUSEA 124 0.0002
521 ENTERITIS 1 0.0002
522 CHOLESTASIS 3 0.0002
523 SKIN ULCER 4 0.0002
524 TENDON DISORDER 1 0.0002
525 NODULE 2 0.0002
526 ASPERGILLUS INFECTION 1 0.0002
527 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
528 SKIN MASS 1 0.0001
529 HYPOTENSION 30 0.0001
530 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
531 COLITIS ISCHAEMIC 1 0.0001
532 METASTASES TO LYMPH NODES 1 0.0001
533 PRODUCT LABEL ISSUE 1 0.0001
534 NEUROPATHY PERIPHERAL 14 0.0001
535 DISEASE RECURRENCE 7 0.0001
536 PNEUMONITIS 4 0.0001
537 GINGIVAL BLEEDING 2 0.0001
538 DEATH 126 0.0001
539 EYE MOVEMENT DISORDER 1 0.0001
540 PRODUCT PREPARATION ERROR 3 0.0001
541 NEPHROTIC SYNDROME 1 0.0001
542 RESPIRATORY DISTRESS 4 0.0001
543 DRUG INTOLERANCE 14 0.0001
544 LYMPHOEDEMA 1 0.0001
545 ENCEPHALITIS 1 0.0001
546 HYPERTRANSAMINASAEMIA 1 0.0001
547 RIGHT VENTRICULAR FAILURE 1 0.0001
548 BLOOD TEST ABNORMAL 2 0.0001
549 RED BLOOD CELL COUNT DECREASED 4 0.0001
550 LIVER FUNCTION TEST INCREASED 3 0.0001
551 CARDIOGENIC SHOCK 2 0.0001
552 DEEP VEIN THROMBOSIS 9 0.0001
553 DERMATITIS BULLOUS 1 0.0001
554 BLOOD CREATININE INCREASED 9 0.0001
555 ORAL DISORDER 1 0.0001
556 ASCITES 4 0.0001
557 LABORATORY TEST ABNORMAL 4 0.0001
558 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
559 CEREBRAL DISORDER 1 0.0001
560 DEHYDRATION 18 0.0001
561 STEVENS-JOHNSON SYNDROME 3 0.0001
562 RASH MACULO-PAPULAR 3 0.0001
563 FEELING DRUNK 1 0.0001
564 HYPERTHERMIA 1 0.0001
565 ACIDOSIS 1 0.0001
566 ACUTE KIDNEY INJURY 20 0.0001
567 PROCEDURAL COMPLICATION 1 0.0001
568 FEMUR FRACTURE 4 0.0001
569 PULMONARY HAEMORRHAGE 1 0.0001
570 ABSCESS 2 0.0001
571 BLOOD DISORDER 1 0.0001
572 OXYGEN SATURATION DECREASED 7 0.0001
573 CARDIAC FAILURE CONGESTIVE 10 0.0001
574 INTERSTITIAL LUNG DISEASE 6 0.0001
575 BLOOD POTASSIUM INCREASED 2 0.0001
576 SHOCK HAEMORRHAGIC 1 0.0001
577 ASPHYXIA 1 0.0001
578 STAPHYLOCOCCAL INFECTION 4 0.0001
579 COAGULOPATHY 2 0.0001
580 CARDIO-RESPIRATORY ARREST 5 0.0001
581 HAEMODIALYSIS 1 0.0001
582 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
583 INFUSION SITE ERYTHEMA 1 0.0001
584 CANDIDA INFECTION 2 0.0001
585 RENAL FAILURE ACUTE 5 0.0001
586 DRUG RESISTANCE 3 0.0001
587 PNEUMONIA 37 0.0001
588 HYPERKALAEMIA 4 0.0001
589 HYPOXIA 4 0.0001
590 IMMUNOSUPPRESSION 1 0.0001
591 DRUG ERUPTION 2 0.0001
592 CEREBRAL HAEMORRHAGE 4 0.0001
593 THERAPY NON-RESPONDER 5 0.0001
594 OEDEMA 6 0.0001
595 ADVERSE EVENT 10 0.0001
596 OVARIAN CANCER 1 0.0001
597 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
598 PRODUCT DISTRIBUTION ISSUE 1 0.0001
599 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
600 ERYTHEMA MULTIFORME 1 0.0001
601 HEPATIC ENCEPHALOPATHY 1 0.0001
602 HEPATIC CIRRHOSIS 2 0.0001
603 PHOTOPHOBIA 2 0.0001
604 PULMONARY EMBOLISM 10 0.0001
605 PRESCRIBED OVERDOSE 2 0.0001
606 LIVER FUNCTION TEST ABNORMAL 3 0.0001
607 EAR PAIN 2 0.0001
608 FATIGUE 80 0.0001
609 PARKINSONISM 1 0.0001
610 HEPATOMEGALY 1 0.0001
611 THERAPY CHANGE 1 0.0001
612 DYSPEPSIA 10 0.0001
613 ASTHENIA 38 0.0001
614 UPPER LIMB FRACTURE 2 0.0001
615 SYNCOPE 10 0.0001
616 EMPHYSEMA 1 0.0001
617 PERITONITIS BACTERIAL 1 0.0001
618 EYELID PTOSIS 1 0.0001
619 MOTOR DYSFUNCTION 1 0.0001
620 INITIAL INSOMNIA 1 0.0001
621 MUSCULAR WEAKNESS 11 0.0001
622 TREATMENT FAILURE 8 0.0001
623 HYPERBILIRUBINAEMIA 1 0.0001
624 SWOLLEN TONGUE 3 0.0001
625 INCONTINENCE 1 0.0001
626 METABOLIC ACIDOSIS 3 0.0001
627 BREAST CANCER METASTATIC 1 0.0001
628 HOT FLUSH 7 0.0001
629 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
630 PRURITUS GENERALISED 2 0.0001
631 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
632 ASPIRATION 1 0.0001
633 GASTROINTESTINAL PAIN 1 0.0001
634 LIP SWELLING 3 0.0001
635 URINARY RETENTION 3 0.0001
636 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
637 HEPATOTOXICITY 2 0.0001
638 PULMONARY OEDEMA 4 0.0001
639 GASTROINTESTINAL DISORDER 8 0.0001
640 SKIN INFECTION 1 0.0001
641 NEPHROPATHY TOXIC 1 0.0001
642 INTESTINAL PERFORATION 1 0.0001
643 BLOOD CALCIUM DECREASED 1 0.0001
644 LETHARGY 5 0.0001
645 GASTRIC HAEMORRHAGE 1 0.0001
646 PERICARDIAL EFFUSION 2 0.0001
647 DELIRIUM 3 0.0001
648 WEIGHT DECREASED 24 0.0001
649 DIARRHOEA 55 0.0001
650 ACCIDENT 1 0.0001
651 HYPERLIPIDAEMIA 1 0.0001
652 POLYNEUROPATHY 1 0.0001
653 ADRENAL INSUFFICIENCY 1 0.0001
654 OEDEMA PERIPHERAL 10 0.0001
655 RESPIRATORY DEPRESSION 1 0.0001
656 DYSPNOEA EXERTIONAL 3 0.0001
657 DERMATITIS ALLERGIC 1 0.0001
658 COLITIS 3 0.0001
659 TACHYCARDIA 7 0.0001
660 HYPOPHAGIA 2 0.0001
661 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
662 CONSTIPATION 17 0.0001
663 INFUSION SITE PAIN 1 0.0001
664 RASH GENERALISED 2 0.0001
665 BEDRIDDEN 1 0.0001
666 GASTRITIS 2 0.0001
667 EYE HAEMORRHAGE 1 0.0001
668 PAIN OF SKIN 2 0.0001
669 THROAT TIGHTNESS 2 0.0001
670 RASH PRURITIC 4 0.0001
671 RHABDOMYOLYSIS 3 0.0001
672 MASS 1 0.0001
673 SKIN EXFOLIATION 6 0.0001
674 DEVICE OCCLUSION 1 0.0001
675 SKIN REACTION 1 0.0001
676 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
677 BRONCHOSPASM 1 0.0001
678 PARAESTHESIA ORAL 1 0.0001
679 DRUG INEFFECTIVE 91 0.0001
680 GASTROENTERITIS 1 0.0001
681 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
682 MALAISE 30 0.0001
683 IMMUNODEFICIENCY 1 0.0001
684 BLOOD POTASSIUM DECREASED 2 0.0001
685 HYPOAESTHESIA ORAL 1 0.0001
686 THERAPEUTIC RESPONSE DECREASED 4 0.0001
687 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
688 BASAL CELL CARCINOMA 1 0.0001
689 OFF LABEL USE 56 0.0001
690 DRUG-INDUCED LIVER INJURY 2 0.0001
691 RASH ERYTHEMATOUS 3 0.0001
692 HYPOTHYROIDISM 2 0.0001
693 INTENTIONAL OVERDOSE 4 0.0001
694 LUNG DISORDER 3 0.0001
695 INFLUENZA LIKE ILLNESS 5 0.0001
696 ABDOMINAL PAIN 14 0.0001
697 FUNGAL INFECTION 2 0.0001
698 PERICARDITIS 1 0.0001
699 TOXICITY TO VARIOUS AGENTS 10 0.0001
700 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
701 HEPATIC ENZYME INCREASED 4 0.0001
702 HAEMOGLOBIN DECREASED 6 0.0001
703 HAEMATURIA 2 0.0001
704 ERYTHEMA 12 0.0001
705 DYSPNOEA 33 0.0001
706 INFLAMMATION 3 0.0001
707 MUSCULOSKELETAL DISCOMFORT 1 0.0001
708 RASH MACULAR 2 0.0001
709 EOSINOPHILIA 1 0.0001
710 PANCREATITIS 3 0.0001
711 BRADYCARDIA 3 0.0001
712 GASTROENTERITIS VIRAL 1 0.0001
713 RASH 24 0.0001
714 TREATMENT NONCOMPLIANCE 3 0.0001
715 RESTLESSNESS 2 0.0001
716 HEPATIC STEATOSIS 1 0.0001
717 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
718 BLOOD SODIUM DECREASED 1 0.0001
719 URINARY TRACT INFECTION 9 0.0001
720 PROTEINURIA 1 0.0001
721 MUSCULOSKELETAL DISORDER 1 0.0001
722 HERPES ZOSTER 3 0.0001
723 PALPITATIONS 6 0.0001
724 ORAL HERPES 1 0.0001
725 SKIN FISSURES 1 0.0001
726 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
727 PRESCRIBED UNDERDOSE 1 0.0001
728 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
729 CONDITION AGGRAVATED 15 0.0000
730 BODY TEMPERATURE INCREASED 1 0.0000
731 PULMONARY HYPERTENSION 1 0.0000
732 PRODUCT USE ISSUE 9 0.0000
733 EATING DISORDER 1 0.0000
734 RETCHING 1 0.0000
735 RECTAL HAEMORRHAGE 2 0.0000
736 POOR QUALITY SLEEP 1 0.0000
737 HEADACHE 29 0.0000
738 PRODUCT DISPENSING ERROR 1 0.0000
739 PRODUCT PRESCRIBING ISSUE 1 0.0000
740 MYOCARDIAL INFARCTION 8 0.0000
741 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
742 APPLICATION SITE PAIN 1 0.0000
743 RENAL FAILURE 6 0.0000
744 FALL 15 0.0000
745 ORAL PAIN 1 0.0000
746 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
747 PANCREATITIS ACUTE 1 0.0000
748 SKIN IRRITATION 2 0.0000
749 INJECTION SITE REACTION 3 0.0000
750 MUSCLE SPASMS 8 0.0000
751 CONFUSIONAL STATE 7 0.0000
752 SEIZURE 5 0.0000
753 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
754 CARDIAC DISORDER 4 0.0000
755 COMA 2 0.0000
756 PRESYNCOPE 1 0.0000
757 NEURALGIA 1 0.0000
758 CEREBRAL INFARCTION 1 0.0000
759 LIVER INJURY 1 0.0000
760 ABASIA 1 0.0000
761 COVID-19 7 0.0000
762 UNEVALUABLE EVENT 3 0.0000
763 COUGH 11 0.0000
764 HYPERHIDROSIS 5 0.0000
765 DIPLOPIA 1 0.0000
766 RESPIRATORY TRACT INFECTION 1 0.0000
767 SEDATION 1 0.0000
768 JAUNDICE 1 0.0000
769 RESPIRATORY ARREST 1 0.0000
770 HAEMATOCHEZIA 2 0.0000
771 FEELING COLD 1 0.0000
772 HAEMOPTYSIS 1 0.0000
773 NECK PAIN 2 0.0000
774 WOUND 1 0.0000
775 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
776 CEREBROVASCULAR ACCIDENT 6 0.0000
777 FLATULENCE 2 0.0000
778 EYE IRRITATION 2 0.0000
779 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
780 URINARY INCONTINENCE 1 0.0000
781 RESPIRATORY DISORDER 1 0.0000
782 APHASIA 1 0.0000
783 HYPERTENSION 7 0.0000
784 FEELING HOT 2 0.0000
785 DIZZINESS 16 0.0000
786 NERVOUS SYSTEM DISORDER 1 0.0000
787 HIP FRACTURE 1 0.0000
788 NIGHT SWEATS 1 0.0000
789 CHOLELITHIASIS 1 0.0000
790 VISUAL ACUITY REDUCED 1 0.0000
791 BLOOD PRESSURE DECREASED 2 0.0000
792 SKIN DISORDER 1 0.0000
793 DRY SKIN 4 0.0000
794 NEOPLASM MALIGNANT 2 0.0000
795 GAIT INABILITY 1 0.0000
796 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
797 CHEST DISCOMFORT 3 0.0000
798 VISION BLURRED 4 0.0000
799 HAEMORRHAGE 3 0.0000
800 HEART RATE DECREASED 1 0.0000
801 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
802 SKIN BURNING SENSATION 2 0.0000
803 DRUG EFFECT INCOMPLETE 1 0.0000
804 DYSURIA 1 0.0000
805 BRONCHITIS 2 0.0000
806 INFLUENZA 3 0.0000
807 EYE SWELLING 1 0.0000
808 INTESTINAL OBSTRUCTION 1 0.0000
809 PAIN 16 0.0000
810 HOSPITALISATION 4 0.0000
811 PRURITUS 10 0.0000
812 PROSTATE CANCER 2 0.0000
813 THROMBOSIS 2 0.0000
814 DRY MOUTH 2 0.0000
815 BLINDNESS 1 0.0000
816 CARDIAC ARREST 2 0.0000
817 POLLAKIURIA 1 0.0000
818 URTICARIA 4 0.0000
819 MYALGIA 4 0.0000
820 HYPOACUSIS 1 0.0000
821 VAGINAL HAEMORRHAGE 1 0.0000
822 MENTAL DISORDER 1 0.0000
823 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
824 SKIN DISCOLOURATION 1 0.0000
825 CHEST PAIN 4 0.0000
826 RENAL DISORDER 1 0.0000
827 BLOOD CHOLESTEROL INCREASED 1 0.0000
828 COGNITIVE DISORDER 1 0.0000
829 PRODUCTIVE COUGH 1 0.0000
830 CONTUSION 2 0.0000
831 HYPOGLYCAEMIA 1 0.0000
832 ALOPECIA 4 0.0000
833 HEART RATE INCREASED 2 0.0000
834 DRY EYE 1 0.0000
835 SINUSITIS 2 0.0000
836 ABDOMINAL PAIN UPPER 4 0.0000
837 ARTHRALGIA 8 0.0000
838 ABDOMINAL DISTENSION 2 0.0000
839 MUSCULOSKELETAL PAIN 1 0.0000
840 DEPRESSED MOOD 1 0.0000
841 DRUG EFFECT DECREASED 1 0.0000
842 ARTHROPATHY 1 0.0000
843 MEDICATION ERROR 1 0.0000
844 BLISTER 1 0.0000
845 DEPRESSION 4 0.0000
846 CONVULSION 1 0.0000
847 BACK PAIN 4 0.0000
848 DYSPHONIA 1 0.0000
849 BONE PAIN 1 0.0000
850 NASAL CONGESTION 1 0.0000
851 BLADDER CANCER 1 0.0000
852 FEELING ABNORMAL 4 0.0000
853 DISCOMFORT 1 0.0000
854 HYPERSENSITIVITY 3 0.0000
855 VISUAL IMPAIRMENT 2 0.0000
856 LOSS OF CONSCIOUSNESS 2 0.0000
857 SWELLING FACE 1 0.0000
858 INFUSION RELATED REACTION 1 0.0000
859 INJECTION SITE PRURITUS 1 0.0000
860 SLEEP DISORDER 1 0.0000
861 THERAPY INTERRUPTED 1 0.0000
862 UNDERDOSE 1 0.0000
863 PAIN IN EXTREMITY 4 0.0000
864 HYPOAESTHESIA 2 0.0000
865 DIABETES MELLITUS 1 0.0000
866 PARAESTHESIA 2 0.0000
867 TREMOR 2 0.0000
868 COMPLETED SUICIDE 1 0.0000
869 ABDOMINAL DISCOMFORT 2 0.0000
870 BALANCE DISORDER 1 0.0000
871 INSOMNIA 3 0.0000
872 SUICIDAL IDEATION 1 0.0000
873 OROPHARYNGEAL PAIN 1 0.0000
874 BREAST CANCER 1 0.0000
875 SWELLING 1 0.0000
876 BLOOD GLUCOSE INCREASED 2 0.0000
877 DYSPHAGIA 1 0.0000
878 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
879 WEIGHT INCREASED 2 0.0000
880 JOINT SWELLING 1 0.0000
881 INJECTION SITE ERYTHEMA 1 0.0000
882 MEMORY IMPAIRMENT 1 0.0000
883 ANXIETY 2 0.0000
884 PRODUCT DOSE OMISSION ISSUE 2 0.0000
885 BLOOD PRESSURE INCREASED 1 0.0000
886 PERIPHERAL SWELLING 1 0.0000
887 DRUG DOSE OMISSION 1 0.0000
888 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
889 NO ADVERSE EVENT 1 0.0000
890 NASOPHARYNGITIS 1 0.0000
891 GAIT DISTURBANCE 1 0.0000
892 OVERDOSE 1 0.0000